First VivaGel BV launch globally in Australia by Aspen
Filed with ASX · · 2 pages · English
Starpharma Holdings Limited on 6ix
Story so far
Earlier from Starpharma
- Starpharma receives $4.0M R&D tax incentive refund
- Interim Report and Half-Yearly Financial Results
- Response to ASX Aware Letter
- VivaGel condom receives final regulatory approval in Japan
- US FDA requests further data for VivaGel BV approval
Later from Starpharma
- DEP irinotecan combination outperforms in colon cancel model
- Starpharma signs second oncology agreement with AstraZeneca
- VivaGel BV launched in Europe
- Starpharma commences phase 1/2 DEP irinotecan trial
- First Asian Regulatory Approvals Received for VivaGel BV
Follow Starpharma into a list and get an email when it puts out news.
Follow Starpharma